- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platelet Rich Plasma in United Kingdom
Total 3107 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMucositis | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
AbbVieCelgeneTerminatedMultiple MyelomaUnited States, Spain, United Kingdom
-
University of LeedsCelgene; Myeloma UKActive, not recruitingMultiple MyelomaUnited Kingdom
-
Northwestern UniversityBTG International Inc.Active, not recruitingThrombocytopenia | CirrhosisUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationImmune Mediated Anemia | Immune Mediated Thrombocytopenia | Chronic GVHDUnited States
-
Lindenwood UniversityCompletedImmune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance ExerciseMuscle Damage | Muscular Fatigue | Immune Markers | Complete Blood Count (CBC) With Platelet Differentials | Muscular Force Production | Countermovement Jump | Muscular SorenessUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
MedsearchUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin Lymphoma | Lymphocyte-Depleted Classical Hodgkin Lymphoma | Lymphocyte-Rich Classical Hodgkin Lymphoma | Mixed Cellularity Classical Hodgkin Lymphoma | Nodular Sclerosis Classical Hodgkin LymphomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
European Myeloma NetworkCompletedAL AmyloidosisNetherlands, Czechia, Austria, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom
-
OncotherapeuticsUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedThrombocytopenia | Anemia, Aplastic | Anemia, HypoplasticUnited States
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
Terumo BCTbioBiomedical Advanced Research and Development AuthorityTerminatedHematologic Malignancies | Hypoproliferative ThrombocytopeniaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoUniversity of Colorado, Denver; University of California, Berkeley; University... and other collaboratorsCompletedWound and Injuries | Blood Platelets | EndotheliumUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fred Hutchinson Cancer CenterCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host DiseaseUnited States
-
Aspen Global IncorporatedTerminatedHeparin-induced ThrombocytopeniaUnited States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingMultiple Myeloma | AL Amyloidosis | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell DyscrasiasUnited States
-
National Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell MyelomaUnited States
-
Escape Bio, Inc.Momentum Pharma; Science 37TerminatedPatients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) GeneUnited States
-
Washington University School of MedicineBristol-Myers Squibb; Damon Runyon Cancer Research FoundationNot yet recruitingClonal Cytopenia of Undetermined Significance | CCUS Clonal Cytopenia of Undetermined SignificanceUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedWaldenstrom Macroglobulinemia | Refractory Plasma Cell Myeloma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia and other conditionsUnited States
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemia | Anemia | Thrombocytopenia | NeutropeniaUnited States
-
The Medicines CompanyCompletedThrombosis | Heparin-Induced ThrombocytopeniaUnited States
-
PfizerCompletedSarcomaUnited States
-
Novartis PharmaceuticalsTerminatedImmune Thrombocytopenia (ITP) | Cold Agglutinin Disease (CAD)United States, Spain, Germany, Korea, Republic of, United Kingdom, Italy
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
GlaxoSmithKlineTerminatedNeoplasms | CancerUnited States, United Kingdom, France
-
The University of Texas Health Science Center,...Active, not recruitingMortality | Cardiac Surgery | Cardiopulmonary Bypass | Cardiac Disease | Arrythmia, Cardiac | Platelet TransfusionUnited States
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingPlasma Cell MyelomaUnited States